SCHEMBL27320877

CC(C)CCC[C@@H](C)C1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)CCCCCCCCCCCCCCCCC(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.84

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	POLA1	P09884	1/20	0.75

▸	CYP46A1	Q9Y6A2	2/20	0.69

▸	USP2	O75604	1/20	0.65

▸	LMNA	P02545	1/20	0.65

▸	ABCB1	P08183	1/20	0.65

▸	OSBP	P22059	1/20	0.65

▸	RORC	P51449	1/20	0.65

▸	OSBP2	Q969R2	1/20	0.65

▸	EPHA2	P29317	1/20	0.63

▸	NR1H3	Q13133	1/20	0.63

▸	PLA2G2A	P14555	1/20	0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL11426770	1.00	POLA1 (0.75)	POLA1CYP46A1USP2LMNAABCB1
SCHEMBL27320821	1.00	POLA1 (0.75)	POLA1CYP46A1USP2LMNAABCB1
SCHEMBL28088866	1.00	POLA1 (0.75)	POLA1CYP46A1USP2LMNAABCB1
SCHEMBL27320857	1.00	POLA1 (0.75)	POLA1CYP46A1USP2LMNAABCB1
SCHEMBL8608992	1.00	POLA1 (0.75)	POLA1CYP46A1USP2LMNAABCB1
SCHEMBL11423844	1.00	POLA1 (0.75)	POLA1CYP46A1USP2LMNAABCB1
SCHEMBL27883156	1.00	POLA1 (0.75)	POLA1CYP46A1USP2LMNAABCB1
Ethane SCHEMBL27501171	0.99	POLA1 (0.74)	POLA1CYP46A1USP2LMNAABCB1
SCHEMBL25351944	0.99	POLA1 (0.77)	POLA1CYP46A1USP2LMNAABCB1
SCHEMBL2134010	0.99	POLA1 (0.77)	POLA1CYP46A1USP2LMNAABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4393484-A1	COMPOSITION FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACID	Themedium Therapeutics Co., Ltd. (CN)	2024-07-03	—	—	EP	disclosed